Literature DB >> 20573093

Acute liver damage due to Serenoa repens: a case report.

Francesco Lapi, Eugenia Gallo, Elisa Giocaliere, Michele Vietri, Roberto Baronti, Giuseppe Pieraccini, Alessandro Tafi, Francesca Menniti-Ippolito, Alessandro Mugelli, Fabio Firenzuoli, Alfredo Vannacci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20573093      PMCID： PMC2856058          DOI： 10.1111/j.1365-2125.2010.03618.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Too much effectiveness from a herbal drug.

Authors:  Alfredo Vannacci; Francesco Lapi; Roberto Baronti; Eugenia Gallo; Luigi Gori; Alessandro Mugelli; Fabio Firenzuoli
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

2.  Protracted cholestatic hepatitis after the use of prostata.

Authors:  S Hamid; S Rojter; J Vierling
Journal:  Ann Intern Med       Date:  1997-07-15       Impact factor: 25.391

3.  Saw palmetto-induced pancreatitis.

Authors:  Ismaila Jibrin; Ayodele Erinle; Abdulfattah Saidi; Zakari Y Aliyu
Journal:  South Med J       Date:  2006-06       Impact factor: 0.954

4.  Hepatotoxicity potential of saw palmetto (Serenoa repens) in rats.

Authors:  Y N Singh; A K Devkota; D C Sneeden; K K Singh; F Halaweish
Journal:  Phytomedicine       Date:  2006-07-18       Impact factor: 5.340

5.  Development of saw palmetto (Serenoa repens) fruit and extract standard reference materials.

Authors:  Michele M Schantz; Mary Bedner; Stephen E Long; John L Molloy; Karen E Murphy; Barbara J Porter; Karsten Putzbach; Catherine A Rimmer; Lane C Sander; Katherine E Sharpless; Jeanice B Thomas; Stephen A Wise; Laura J Wood; James H Yen; Takashi Yarita; Agnes NguyenPho; Wendy R Sorenson; Joseph M Betz
Journal:  Anal Bioanal Chem       Date:  2008-08-02       Impact factor: 4.142

6.  A detailed safety assessment of a saw palmetto extract.

Authors:  Andrew L Avins; Stephen Bent; Suzanne Staccone; Evelyn Badua; Amy Padula; Harley Goldberg; John Neuhaus; Esther Hudes; Katusto Shinohara; Christopher Kane
Journal:  Complement Ther Med       Date:  2008-02-20       Impact factor: 2.446

Review 7.  Serenoa repens for benign prostatic hyperplasia.

Authors:  James Tacklind; Roderick MacDonald; Indy Rutks; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 8.  Causality assessment in hepatotoxicity by drugs and dietary supplements.

Authors:  Rolf Teschke; Alexander Schwarzenboeck; Karl-Heinz Hennermann
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

9.  Saw palmetto for benign prostatic hyperplasia.

Authors:  Stephen Bent; Christopher Kane; Katsuto Shinohara; John Neuhaus; Esther S Hudes; Harley Goldberg; Andrew L Avins
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

10.  Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

Authors:  F Di Silverio; S Monti; A Sciarra; P A Varasano; C Martini; S Lanzara; G D'Eramo; S Di Nicola; V Toscano
Journal:  Prostate       Date:  1998-10-01       Impact factor: 4.104
View more
  4 in total

1.  Safety and toxicity of saw palmetto in the CAMUS trial.

Authors:  Andrew L Avins; Jeannette Y Lee; Catherine M Meyers; Michael J Barry
Journal:  J Urol       Date:  2012-10-09       Impact factor: 7.450

Review 2.  Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps.

Authors:  Rolf Teschke; Axel Eickhoff
Journal:  Front Pharmacol       Date:  2015-04-23       Impact factor: 5.810

Review 3.  Lower urinary tract symptoms in men.

Authors:  John M Hollingsworth; Timothy J Wilt
Journal:  BMJ       Date:  2014-08-14

Review 4.  Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.

Authors:  Christian Frenzel; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.